Products
Online Inquiry
FB23-2
Cat. No.:
OB0125LY-087
Appearance:
Solid
Purity:
98%
Identity:
Confirmed by NMR and HPLC.
Size:
Add to basket
Product Overview
Description:
FB23-2 is a selective inhibitor that inhibits mRNA N6-methyladenosine (m6A) demethylase FTO.
Synonym:
2243736-45-8; 2-( (2,6-Dichloro-4-(3,5-dimethylisoxazol-4-yl)phenyl)amino)-N-hydroxybenzamide; 2-[2,6-Dichloro-4-(3,5-dimethyl-1,2-oxazol-4-yl)anilino]-N-hydroxybenzamide; 2-{[2,6-Dichloro-4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]amino}N-hydroxybenzamide
CAS No.:
2243736-45-8
Compound CID:
138454779
Formula:
C18H15Cl2N3O3
Formula Weight:
392.24
Specification
Targets & IC50:
FTO: 2.6 μM (IC50)
Relative Density:
1.428 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
FB23-2 is mainly used in biomedical research, especially in cancer research, to explore its potential as an anti-tumor drug.
Library Information
Targets:
Apoptosis
Receptors:
Apoptosis; mRNA N6-methyladenosine (m6A) demethylase FTO
Pathways:
Apoptosis
Plate Number:
AOCL-31
Plate Location:
e9
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
1 mg/mL;
![[6]-Gingerol](https://www.obesityscientific.com/wp-content/themes/obesity/images/product/0225LY-0989.jpg)